ARKAY
Price
$76.44
Change
+$0.21 (+0.28%)
Updated
Jul 25 closing price
Capitalization
8.05B
4 days until earnings call
JMPLY
Price
$49.90
Change
-$0.98 (-1.93%)
Updated
Jul 24 closing price
Capitalization
4.25B
One day until earnings call
Interact to see
Advertisement

ARKAY vs JMPLY

Header iconARKAY vs JMPLY Comparison
Open Charts ARKAY vs JMPLYBanner chart's image
Arkema
Price$76.44
Change+$0.21 (+0.28%)
Volume$9.93K
Capitalization8.05B
Johnson Matthey
Price$49.90
Change-$0.98 (-1.93%)
Volume$1.36K
Capitalization4.25B
ARKAY vs JMPLY Comparison Chart in %
Loading...
ARKAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JMPLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARKAY vs. JMPLY commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARKAY is a Hold and JMPLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ARKAY: $76.44 vs. JMPLY: $49.90)
Brand notoriety: ARKAY and JMPLY are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: ARKAY: 66% vs. JMPLY: 55%
Market capitalization -- ARKAY: $8.05B vs. JMPLY: $4.25B
ARKAY [@Chemicals: Specialty] is valued at $8.05B. JMPLY’s [@Chemicals: Specialty] market capitalization is $4.25B. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $223.16B to $0. The average market capitalization across the [@Chemicals: Specialty] industry is $9.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARKAY’s FA Score shows that 1 FA rating(s) are green whileJMPLY’s FA Score has 0 green FA rating(s).

  • ARKAY’s FA Score: 1 green, 4 red.
  • JMPLY’s FA Score: 0 green, 5 red.
According to our system of comparison, JMPLY is a better buy in the long-term than ARKAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARKAY’s TA Score shows that 5 TA indicator(s) are bullish while JMPLY’s TA Score has 2 bullish TA indicator(s).

  • ARKAY’s TA Score: 5 bullish, 4 bearish.
  • JMPLY’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ARKAY is a better buy in the short-term than JMPLY.

Price Growth

ARKAY (@Chemicals: Specialty) experienced а +4.57% price change this week, while JMPLY (@Chemicals: Specialty) price change was -0.41% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +2.16%. For the same industry, the average monthly price growth was +6.25%, and the average quarterly price growth was +3.19%.

Reported Earning Dates

ARKAY is expected to report earnings on Jul 31, 2025.

JMPLY is expected to report earnings on Jul 28, 2025.

Industries' Descriptions

@Chemicals: Specialty (+2.16% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARKAY($8.05B) has a higher market cap than JMPLY($4.25B). ARKAY has higher P/E ratio than JMPLY: ARKAY (14.29) vs JMPLY (12.50). JMPLY YTD gains are higher at: 55.685 vs. ARKAY (13.126). ARKAY has higher annual earnings (EBITDA): 1.41B vs. JMPLY (621M). ARKAY has more cash in the bank: 1.67B vs. JMPLY (650M). JMPLY has less debt than ARKAY: JMPLY (1.66B) vs ARKAY (3.61B). JMPLY has higher revenues than ARKAY: JMPLY (14.9B) vs ARKAY (10.4B).
ARKAYJMPLYARKAY / JMPLY
Capitalization8.05B4.25B189%
EBITDA1.41B621M228%
Gain YTD13.12655.68524%
P/E Ratio14.2912.50114%
Revenue10.4B14.9B70%
Total Cash1.67B650M256%
Total Debt3.61B1.66B217%
FUNDAMENTALS RATINGS
ARKAY vs JMPLY: Fundamental Ratings
ARKAY
JMPLY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
9786
SMR RATING
1..100
8479
PRICE GROWTH RATING
1..100
5139
P/E GROWTH RATING
1..100
6198
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARKAY's Valuation (12) in the null industry is in the same range as JMPLY (34). This means that ARKAY’s stock grew similarly to JMPLY’s over the last 12 months.

JMPLY's Profit vs Risk Rating (86) in the null industry is in the same range as ARKAY (97). This means that JMPLY’s stock grew similarly to ARKAY’s over the last 12 months.

JMPLY's SMR Rating (79) in the null industry is in the same range as ARKAY (84). This means that JMPLY’s stock grew similarly to ARKAY’s over the last 12 months.

JMPLY's Price Growth Rating (39) in the null industry is in the same range as ARKAY (51). This means that JMPLY’s stock grew similarly to ARKAY’s over the last 12 months.

ARKAY's P/E Growth Rating (61) in the null industry is somewhat better than the same rating for JMPLY (98). This means that ARKAY’s stock grew somewhat faster than JMPLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARKAYJMPLY
RSI
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
54%
Bearish Trend 3 days ago
68%
MACD
ODDS (%)
Bullish Trend 3 days ago
54%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
57%
Advances
ODDS (%)
Bullish Trend 5 days ago
56%
Bullish Trend 5 days ago
61%
Declines
ODDS (%)
Bearish Trend 11 days ago
61%
Bearish Trend 12 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
Bullish Trend 5 days ago
45%
Bullish Trend 3 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
ARKAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JMPLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PNOV40.180.12
+0.30%
Innovator US Equity Power Buffer ETF Nov
HEAL10.620.01
+0.13%
Global X HealthTech ETF
VXZ57.720.03
+0.05%
iPath® B S&P 500® VIX Md-Trm Futs™ ETN
HEEM30.97-0.02
-0.05%
iShares Currency Hedged MSCI Em Mkts ETF
VSS137.11-0.13
-0.09%
Vanguard FTSE All-Wld ex-US SmCp ETF

ARKAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARKAY has been loosely correlated with BASFY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ARKAY jumps, then BASFY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARKAY
1D Price
Change %
ARKAY100%
+0.28%
BASFY - ARKAY
63%
Loosely correlated
+0.52%
AKZOY - ARKAY
58%
Loosely correlated
+1.00%
SXYAY - ARKAY
48%
Loosely correlated
+1.55%
JMPLY - ARKAY
46%
Loosely correlated
N/A
BNTGY - ARKAY
41%
Loosely correlated
+0.90%
More

JMPLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, JMPLY has been loosely correlated with BASFY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if JMPLY jumps, then BASFY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JMPLY
1D Price
Change %
JMPLY100%
N/A
BASFY - JMPLY
50%
Loosely correlated
+0.52%
SXYAY - JMPLY
49%
Loosely correlated
+1.55%
AKZOY - JMPLY
47%
Loosely correlated
+1.00%
ARKAY - JMPLY
46%
Loosely correlated
+0.28%
BNTGY - JMPLY
41%
Loosely correlated
+0.90%
More